CompaniesAviragen Therapeutics

Aviragen Therapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (1)
View all

Total Trials

1

As Lead Sponsor

1

As Collaborator

0

Total Enrollment

48

By Phase

PHASE1: 1

By Status

COMPLETED: 1
Clinical Trials Pipeline1 trial
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
Funding History (20)
8-K
Oct 10, 2025
8-K
Sep 19, 2025
8-K
Sep 19, 2025
DEFA14A
Sep 8, 2025
8-K
Sep 8, 2025
8-K
Sep 2, 2025
8-K
Aug 29, 2025
DEFA14A
Aug 21, 2025
8-K
Aug 21, 2025
DEFA14A
Aug 15, 2025
Related Companies
Reverse Merger By Vaxart
acquired